Fig. 3.
CD80 expression in a panel of 7 human leukemia cell lines transduced with pHR-CD80 or pHR-GM/CD.
The percentage of CD80-positive (CD80+) cells in the fluorescence-activated cell-sorter analysis was calculated by subtracting the frequency of the transduced cells from the background (mock-transduced) controls.